These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 36569165)
1. The diagnosis of Adamantiades-Behçet disease: Clinical features and diagnostic/classification criteria. Bergamo S Front Med (Lausanne); 2022; 9():1098351. PubMed ID: 36569165 [TBL] [Abstract][Full Text] [Related]
2. Adamantiades-Behçet Disease at the Beginning of the Silk Route: North-East Italian Experience. Bergamo S; di Meo N; Stinco G; Bonin S; Trevisini S; Trevisan G Acta Dermatovenerol Croat; 2017 Dec; 25(4):295-297. PubMed ID: 30064603 [TBL] [Abstract][Full Text] [Related]
3. Analysis of diagnostic criteria in adamantiades-behçet disease: a retrospective study. di Meo N; Bergamo S; Vidimari P; Bonin S; Trevisan G Indian J Dermatol; 2013 Jul; 58(4):275-7. PubMed ID: 23918996 [TBL] [Abstract][Full Text] [Related]
4. Benediktos Adamantiades and his forgotten contributions to medicine. Zouboulis CC Eur J Dermatol; 2002; 12(5):471-4. PubMed ID: 12370138 [TBL] [Abstract][Full Text] [Related]
5. The physician B. Adamantiades and his contribution to the disease Adamantiades-Behçet. Dimakakos PB; Tsiligiris B; Kotsis T Int Angiol; 1999 Jun; 18(2):176-81. PubMed ID: 10424377 [TBL] [Abstract][Full Text] [Related]
6. A study of the use of Behçet/Behçet's disease or syndrome with or without Adamantiades in the medical literature during the past two decades. Turgut YB; Sargın G Eur J Rheumatol; 2021 Apr; 8(2):84-88. PubMed ID: 33226329 [TBL] [Abstract][Full Text] [Related]
7. Local (topical and intraocular) therapy for ocular Adamantiades-Behçet's disease. Fabiani C; Alió JL Curr Opin Ophthalmol; 2015 Nov; 26(6):546-52. PubMed ID: 26367091 [TBL] [Abstract][Full Text] [Related]
8. Gender-specific differences in Adamantiades-Behçet's disease manifestations: an analysis of the German registry and meta-analysis of data from the literature. Bonitsis NG; Luong Nguyen LB; LaValley MP; Papoutsis N; Altenburg A; Kötter I; Micheli C; Maldini C; Mahr A; Zouboulis CC Rheumatology (Oxford); 2015 Jan; 54(1):121-33. PubMed ID: 25118314 [TBL] [Abstract][Full Text] [Related]
9. Epidemiological features of Adamantiades-Behçet's disease in Germany and in Europe. Zouboulis CC; Kötter I; Djawari D; Kirch W; Kohl PK; Ochsendorf FR; Keitel W; Stadler R; Wollina U; Proksch E; Söhnchen R; Weber H; Gollnick HP; Hölzle E; Fritz K; Licht T; Orfanos CE Yonsei Med J; 1997 Dec; 38(6):411-22. PubMed ID: 9509911 [TBL] [Abstract][Full Text] [Related]
10. Adamantiades-Behçet disease: from clinical heterogeneity to diagnosis during the COVID-19 pandemic. Trevisan G; Trevisini S; Bergamo S; Meo ND; Bonin S; Ruscio M; Marini M; Gaggino A; Urban F; Pascazio L Minerva Cardiol Angiol; 2022 Aug; 70(4):502-521. PubMed ID: 35212505 [TBL] [Abstract][Full Text] [Related]
11. Adamantiades-Behçet's disease therapy: current treatment options and recommendations with regard to the COVID-19 pandemic. Trevisini S; Trevisan G; Zalaudek I; Bonin S Dermatol Ther; 2022 Mar; 35(3):e15286. PubMed ID: 34962035 [TBL] [Abstract][Full Text] [Related]
18. Vascular manifestations of Behcet's disease: report of a case and review of the literature. Kotsis T; Moulakakis KG; Mylonas S; Andrikopoulos V Phlebology; 2011 Sep; 26(6):249-53. PubMed ID: 21478143 [TBL] [Abstract][Full Text] [Related]
19. Treatment of Adamantiades-Behçet disease with systemic interferon alfa. Zouboulis CC; Orfanos CE Arch Dermatol; 1998 Aug; 134(8):1010-6. PubMed ID: 9722733 [TBL] [Abstract][Full Text] [Related]
20. Incidence, prevalence, and mortality of Adamantiades-Behçet's disease in Korea: a nationwide, population-based study (2006-2015). Lee YB; Lee SY; Choi JY; Lee JH; Chae HS; Kim JW; Han KD; Park YG; Yu DS J Eur Acad Dermatol Venereol; 2018 Jun; 32(6):999-1003. PubMed ID: 28940547 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]